Out of the glucagon-positive cells (excluding the rarer phenotypes with any combination of insulin and/or PDX1), the median proportion of glucagon-positive cells expressing ARX was 26% and 22% in the T1D and control groups, respectively (p = 0.6, Fig. 4a, c, and d). This evidence concerns the gene GCG and type 1 diabetes mellitus.